• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚焦文库,核心结构从天然产物中提取并修饰:在磷酸酶抑制剂和多种生化发现中的应用。

Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.

机构信息

Synthetic Organic Chemistry Laboratory, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.

RIKEN Center for Sustainable Resource Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.

出版信息

Acc Chem Res. 2015 May 19;48(5):1464-73. doi: 10.1021/acs.accounts.5b00048. Epub 2015 Apr 20.

DOI:10.1021/acs.accounts.5b00048
PMID:25894598
Abstract

Synthesis of a focused library is an important strategy to create novel modulators of specific classes of proteins. Compounds in a focused library are composed of a common core structure and different diversity structures. In this Account, we describe our design and synthesis of libraries focused on selective inhibitors of protein phosphatases (PPases). We considered that core structures having structural and electronic features similar to those of PPase substrates, phosphate esters, would be a reasonable choice. Therefore, we extracted core structures from natural products already identified as PPase inhibitors. Since many PPases share similar active-site structures, such phosphate-mimicking core structures should interact with many enzymes in the same family, and therefore the choice of diversity structures is pivotal both to increase the binding affinity and to achieve specificity for individual enzymes. Here we present case studies of application of focused libraries to obtain PPase inhibitors, covering the overall process from selection of core structures to identification and evaluation of candidates in the focused libraries. To synthesize a library focused on protein serine-threonine phosphatases (PPs), we chose norcantharidin as a core structure, because norcantharidin dicarboxylate shows a broad inhibition profile toward several PPs. From the resulting focused library, we identified a highly selective PP2B inhibitor, NCA-01. On the other hand, to find inhibitors of dual-specificity protein phosphatases (DSPs), we chose 3-acyltetronic acid extracted from natural product RK-682 as a core structure, because its structure resembles the transition state in the dephosphorylation reaction of DSPs. However, a highly selective inhibitor was not found in the resulting focused library. Furthermore, an inherent drawback of compounds having the highly acidic 3-acyltetronic acid as a core structure is very weak potency in cellulo, probably due to poor cell membrane permeability. Therefore, we next modified the core structure from acidic to neutral by transformation to the enamine derivative and constructed a second-generation focused library (RE derivatives). The resulting compounds showed dramatically improved cell membrane permeability and inhibitory selectivity and included VHR (vaccinia VH1-related)-selective RE12 and CDC25A/B (cell division cycle 25A/B)-selective RE44. These inhibitors act on target enzymes in cellulo and do not generate reactive oxygen species, which is a potential problem with quinoid-type inhibitors of CDC25s. The cellular activity of RE12 was further improved by replacement of the side chain to afford RE176, which showed more potent antiproliferative activity than RE12 against HeLa cells. The dramatic change of inhibitory selectivity obtained by core structure modification from 3-acyltetronic acid to its enamine derivative was associated with a change in the mode of action. Namely, RE derivatives were found to be noncompetitive inhibitors with respect to a small-molecular substrate of CDC25A/B, whereas RK-682 was a competitive inhibitor of VHR. We identified the binding site of RE derivatives on the CDC25A as a pocket adjacent to the active site; this appears to be a promising target site for development of further novel inhibitors of CDC25s.

摘要

聚焦文库的合成是创造特定蛋白类别新型调节剂的重要策略。聚焦文库中的化合物由共同的核心结构和不同的多样性结构组成。在本报告中,我们描述了我们设计和合成针对蛋白磷酸酶(PPases)选择性抑制剂的文库。我们认为,具有与 PPase 底物、磷酸酯相似的结构和电子特征的核心结构是一个合理的选择。因此,我们从已被鉴定为 PPase 抑制剂的天然产物中提取了核心结构。由于许多 PPases 具有相似的活性位点结构,因此这种类似磷酸的核心结构应该与同一家族中的许多酶相互作用,因此多样性结构的选择对于提高结合亲和力和实现对单个酶的特异性都至关重要。在这里,我们介绍了应用聚焦文库获得 PPase 抑制剂的案例研究,涵盖了从核心结构选择到鉴定和评估聚焦文库中候选物的整个过程。为了合成针对蛋白丝氨酸-苏氨酸磷酸酶(PPs)的文库,我们选择去甲斑蝥素作为核心结构,因为去甲斑蝥素二羧酸酯对几种 PPs 具有广泛的抑制谱。从由此产生的聚焦文库中,我们鉴定出一种高度选择性的 PP2B 抑制剂 NCA-01。另一方面,为了寻找双特异性蛋白磷酸酶(DSPs)的抑制剂,我们选择了从天然产物 RK-682 中提取的 3-酰基四氢酸作为核心结构,因为其结构类似于 DSPs 去磷酸化反应的过渡态。然而,在由此产生的聚焦文库中并没有发现高度选择性的抑制剂。此外,具有高度酸性 3-酰基四氢酸作为核心结构的化合物的固有缺点是在细胞内的效力非常弱,这可能是由于细胞膜通透性差所致。因此,我们接下来通过转化为烯胺衍生物将核心结构从酸性转化为中性,并构建了第二代聚焦文库(RE 衍生物)。所得化合物显示出显著改善的细胞膜通透性和抑制选择性,包括对 VHR(痘苗病毒 VH1 相关)具有选择性的 RE12 和对 CDC25A/B(细胞分裂周期 25A/B)具有选择性的 RE44。这些抑制剂在细胞内作用于靶酶,不会产生活性氧物种,这是 CDC25 类醌抑制剂的一个潜在问题。通过将侧链替换为 RE176,进一步提高了 RE12 对 HeLa 细胞的抗增殖活性,从而进一步改善了 RE12 的细胞活性。从 3-酰基四氢酸到其烯胺衍生物的核心结构修饰所获得的抑制选择性的显著变化与作用方式的变化有关。即,发现 RE 衍生物是 CDC25A/B 的小分子底物的非竞争性抑制剂,而 RK-682 是 VHR 的竞争性抑制剂。我们确定了 RE 衍生物在 CDC25A 上的结合位点是活性位点附近的一个口袋;这似乎是开发进一步新型 CDC25 抑制剂的有前途的靶标位点。

相似文献

1
Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.聚焦文库,核心结构从天然产物中提取并修饰:在磷酸酶抑制剂和多种生化发现中的应用。
Acc Chem Res. 2015 May 19;48(5):1464-73. doi: 10.1021/acs.accounts.5b00048. Epub 2015 Apr 20.
2
A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.一个源自合理核心设计和随机侧链变异的小分子、酪氨酸和双特异性磷酸酶抑制剂的靶向文库。
Biochemistry. 1997 Dec 16;36(50):15965-74. doi: 10.1021/bi971338h.
3
[Development of novel types of biologically active compounds based on natural products and biomolecules].基于天然产物和生物分子的新型生物活性化合物的开发
Yakugaku Zasshi. 2012;132(1):117-24. doi: 10.1248/yakushi.132.117.
4
Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.以酪氨酸和双特异性蛋白磷酸酶抑制剂为重点的四氢吡喃酮酸文库的合成及其对VHR和cdc25B抑制作用的评估。
J Med Chem. 2001 Sep 27;44(20):3216-22. doi: 10.1021/jm0100741.
5
Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.RK-682是一种非特异性酶抑制剂吗?外消旋RK-682及其类似物对蛋白酪氨酸磷酸酶抑制作用的合成与体外评估。
Eur J Med Chem. 2015 Jun 5;97:42-54. doi: 10.1016/j.ejmech.2015.04.036. Epub 2015 Apr 20.
6
VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates.VHR和PTP1蛋白磷酸酶对低分子量非肽底物表现出显著不同的活性位点特异性。
Biochemistry. 1996 Jul 23;35(29):9349-54. doi: 10.1021/bi960700+.
7
Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory activity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition.RK-682二聚体衍生物的设计与合成,该衍生物对双特异性ERK磷酸酶VHR的抑制活性增强:对抑制分子机制的启示
Chem Biol. 2001 Dec;8(12):1209-20. doi: 10.1016/s1074-5521(01)00089-8.
8
RE12 derivatives displaying Vaccinia H1-related phosphatase (VHR) inhibition in the presence of detergent and their anti-proliferative activity against HeLa cells.
Bioorg Med Chem. 2014 May 1;22(9):2771-82. doi: 10.1016/j.bmc.2014.03.012. Epub 2014 Mar 18.
9
Development of a Vaccinia H1-related (VHR) phosphatase inhibitor with a nonacidic phosphate-mimicking core structure.具有非酸性磷酸模拟核心结构的痘苗H1相关(VHR)磷酸酶抑制剂的研发。
ChemMedChem. 2011 Apr 4;6(4):617-22. doi: 10.1002/cmdc.201100107. Epub 2011 Mar 9.
10
A potent and selective inhibitor for the UBLCP1 proteasome phosphatase.一种针对UBLCP1蛋白酶体磷酸酶的强效选择性抑制剂。
Bioorg Med Chem. 2015 Jun 15;23(12):2798-809. doi: 10.1016/j.bmc.2015.03.066. Epub 2015 Mar 31.

引用本文的文献

1
Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass.从生物质中获取具有生物活性的去甲斑蝥素衍生物的简便化学方法。
Molecules. 2017 Dec 12;22(12):2210. doi: 10.3390/molecules22122210.
2
F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414.F-36316 A和B是从Incrucipulum sp. SANK 10414中分离出的新型血管活性化合物。
J Antibiot (Tokyo). 2017 Oct;70(10):981-986. doi: 10.1038/ja.2017.84. Epub 2017 Aug 9.